CCS
OMCL icon

Crosspoint Capital Strategies’s Omnicell OMCL Stock Holding History

Crosspoint Capital Strategies’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-100
Closed -$3K – 603
2014
Q1 		$3K Hold
100
– – ﹤0.01% 621
2013
Q4 		$3K Buy
+100
New +$2.39K ﹤0.01% 528

Other funds holding OMCL

ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Crosspoint Capital Strategies's OMCL Position: Q2 2014 in Review

Crosspoint Capital Strategies sold out of Omnicell (OMCL) in Q2 2014, closing a stake of 100 shares — an estimated $3K sold.

Crosspoint Capital Strategies first reported a position in OMCL in Q4 2013 and held it in 2 quarters. The position peaked at $3K in Q1 2014. 172 funds tracked by Wall St. Rank hold OMCL as of Q2 2014.

  • Crosspoint Capital Strategies reported no remaining Omnicell position as of Q2 2014 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 100 Omnicell shares in Q2 2014, an estimated $3K.
  • Crosspoint Capital Strategies first reported a position in Omnicell in Q4 2013 and held it in 2 quarters.
  • Crosspoint Capital Strategies's Omnicell position peaked at $3K in Q1 2014.
  • 172 funds tracked by Wall St. Rank held Omnicell as of Q2 2014.

Based on Crosspoint Capital Strategies's 13F filing for Q2 2014, filed 29 Jul 2014.